These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Chan AC; Chan KW; Chan JK; Au WY; Ho WK; Ng WM Histopathology; 2001 Jun; 38(6):510-8. PubMed ID: 11422494 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease. Sun X; Chang KC; Abruzzo LV; Lai R; Younes A; Jones D Hum Pathol; 2003 Sep; 34(9):835-40. PubMed ID: 14562277 [TBL] [Abstract][Full Text] [Related]
5. Transformation of Castleman's disease into follicular dendritic cell sarcoma, presenting as an asymptomatic intra-abdominal mass. Hwang SO; Lee TH; Bae SH; Cho HD; Choi KH; Park SH; Kim CH; Kim SJ Korean J Gastroenterol; 2013 Aug; 62(2):131-4. PubMed ID: 23981949 [TBL] [Abstract][Full Text] [Related]
6. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells. Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293 [TBL] [Abstract][Full Text] [Related]
7. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases. Lin O; Frizzera G Am J Surg Pathol; 1997 Nov; 21(11):1295-306. PubMed ID: 9351567 [TBL] [Abstract][Full Text] [Related]
8. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation. Iagaru A; Mari C; Sam Gambhir S Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947 [TBL] [Abstract][Full Text] [Related]
9. Cytologic demonstration of "dysplastic" follicular dendritic cells in a case of hyaline-vascular Castleman's disease. Taylor GB; Smeeton IW Diagn Cytopathol; 2000 Apr; 22(4):230-4. PubMed ID: 10787143 [TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Chan JK; Fletcher CD; Nayler SJ; Cooper K Cancer; 1997 Jan; 79(2):294-313. PubMed ID: 9010103 [TBL] [Abstract][Full Text] [Related]
11. Follicular dendritic cell sarcoma aggravated by hyaline-vascular Castleman's disease in association with paraneoplastic pemphigus: study of the tumor and successful treatment. Wang J; Wang X; Xu J; Song P An Bras Dermatol; 2019; 94(5):578-581. PubMed ID: 31777359 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Nishi J; Maruyama I Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746 [TBL] [Abstract][Full Text] [Related]
13. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Nguyen DT; Diamond LW; Hansmann ML; Alavaikko MJ; Schröder H; Fellbaum C; Fischer R Histopathology; 1994 May; 24(5):437-43. PubMed ID: 8088715 [TBL] [Abstract][Full Text] [Related]
14. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells. Ruco LP; Gearing AJ; Pigott R; Pomponi D; Burgio VL; Cafolla A; Baiocchini A; Baroni CD Histopathology; 1991 Dec; 19(6):523-8. PubMed ID: 1723957 [TBL] [Abstract][Full Text] [Related]
15. Castleman's disease associated with myasthenia gravis. Day JR; Bew D; Ali M; Dina R; Smith PL Ann Thorac Surg; 2003 May; 75(5):1648-50. PubMed ID: 12735602 [TBL] [Abstract][Full Text] [Related]
16. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity? O'Leary J; Kennedy M; Howells D; Silva I; Uhlmann V; Luttich K; Biddolph S; Lucas S; Russell J; Bermingham N; O'Donovan M; Ring M; Kenny C; Sweeney M; Sheils O; Martin C; Picton S; Gatter K Mol Pathol; 2000 Apr; 53(2):69-76. PubMed ID: 10889905 [TBL] [Abstract][Full Text] [Related]
17. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease. Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826 [TBL] [Abstract][Full Text] [Related]
18. HHV-8 is not associated with follicular dendritic cell tumours. Nayler SJ; Taylor L; Cooper K Mol Pathol; 1998 Jun; 51(3):168-70. PubMed ID: 9850342 [TBL] [Abstract][Full Text] [Related]
19. [Intrahepatic sarcoma of the follicular dendritic cells]. Fritzsche FR; Bode B; Thies S; Donati OF; Schiesser M; Clavien PA; Jochum W Pathologe; 2010 Mar; 31(2):153-6. PubMed ID: 19565242 [TBL] [Abstract][Full Text] [Related]
20. Castleman's disease associated with follicular dendritic cell sarcoma and myasthenia gravis. Westphal FL; Lima LC; Santana LC; Netto JC; Amaral VC; Silva Mdos S J Bras Pneumol; 2010; 36(6):819-23. PubMed ID: 21225186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]